Trial
NCT00819221
AZD2281 in Combination With Liposomal Doxorubicin in Advanced Solid Tumours
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
AstraZeneca
Collaborators
—
Condition
Solid Tumors
Intervention
AZD2281
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-30